Literature DB >> 16256055

Acute hepatitis and atovaquone/proguanil.

Matthias Grieshaber1, Jürg Lämmli, Louis Marcus.   

Abstract

A 31-year-old healthy man developed acute hepatitis after receiving atovaquone (250 mg) and proguanil (100 mg) for malaria prophylaxis daily for 25 days. Although atovaquone/proguanil is generally well-tolerated, this case highlights the hepatotoxic potential with considerable morbidity and should alert physicians to this harmful side effect.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16256055     DOI: 10.2310/7060.2005.12510

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  2 in total

1.  If DILI Is Suspected, Don't Dally.

Authors:  Aamer Abbass; Sameen Khalid; Umer Farooq; Neal Rakov; Joshua Hanson; David Martin; Denis McCarthy
Journal:  Dig Dis Sci       Date:  2021-01-05       Impact factor: 3.199

2.  Atovaquone/proguanil-induced autoimmune-like hepatitis.

Authors:  Benedetta Terziroli Beretta-Piccoli; Giorgina Mieli-Vergani; Raffaela Bertoli; Luca Mazzucchelli; Charity Nofziger; Markus Paulmichl; Diego Vergani
Journal:  Hepatol Commun       Date:  2017-05-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.